Stock listing

6MK Stock Price, News, Filings & Events — Merck & Company, Inc.

Selected listing: 6MK · TRADEGATE · EUR · DE

6MK:TRADEGATE represents Merck & Company, Inc., a prominent American pharmaceutical firm recognized for its innovative healthcare solutions. The company focuses on developing a diverse portfolio of prescription medicines, vaccines, and biologic therapies aimed at enhancing patient outcomes. Recent news and filings highlight Merck's ongoing commitment to research and development in the pharmaceutical sector, reflecting its significant role in the healthcare market. Investors can stay informed about upcoming events and market trends that may impact Merck's operations and strategic direction.

6MK:TRADEGATEEURDEUpdated July 31, 2026
Merck & Company, Inc. logo
Ticker
6MK:TRADEGATE
Asset type
Stock
Market cap
$321.57B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
TRADEGATE
Currency
EUR

Merck & Company, Inc. 6MK:TRADEGATE stock context

6MK:TRADEGATE represents Merck & Company, Inc., a prominent American pharmaceutical firm recognized for its innovative healthcare solutions. The company focuses on developing a diverse portfolio of prescription medicines, vaccines, and biologic therapies aimed at enhancing patient outcomes. Recent news and filings highlight Merck's ongoing commitment to research and development in the pharmaceutical sector, reflecting its significant role in the healthcare market. Investors can stay informed about upcoming events and market trends that may impact Merck's operations and strategic direction.

Research Merck & Company, Inc.

Alternate listings